| dc.contributor.author | Ponyi, Andrea | |
| dc.contributor.author | Borgulya G, | |
| dc.contributor.author | Constantin, Tamás | |
| dc.contributor.author | Váncsa, Andrea | |
| dc.contributor.author | Gergely, Lajos | |
| dc.contributor.author | Dankó, Katalin | |
| dc.date.accessioned | 2018-06-20T13:10:58Z | |
| dc.date.available | 2018-06-20T13:10:58Z | |
| dc.date.issued | 2005 | |
| dc.identifier | 12344327640 | |
| dc.identifier.citation | pagination=83-88; journalVolume=44; journalIssueNumber=1; journalTitle=RHEUMATOLOGY (UNITED KINGDOM); | |
| dc.identifier.uri | http://repo.lib.semmelweis.hu//handle/123456789/4260 | |
| dc.identifier.uri | doi:10.1093/rheumatology/keh404 | |
| dc.description.abstract | OBJECTIVES: To present the outcome of patients with idiopathic inflammatory myositis, focusing on functional ability and quality of life. METHODS: Analysis was performed using data from 105 adult patients with definitive polymyositis, dermatomyositis or overlap myositis, who were followed up at a single centre. The diagnosis was made between 1979 and 2000 based on Bohan and Peter's criteria. Functional ability was assessed after a minimum follow-up of 3 yr with the Health Assessment Questionnaire Disability Index (HAQDI) and quality of life was measured with the Short Form 36-item questionnaire (SF-36). RESULTS: Fifteen patients in our cohort died and 87 participated in the evaluation of functional outcome. Functional ability after a median follow-up of 107.1 months (range 36.4-273.3) was heterogeneous. The median HAQDI score was 0.875 (range 0-2.875). Polyphasic or chronic-progressive disease course, osteoporosis and long-term follow-up were predictive of higher HAQDI scores. In terms of quality of life, significant differences from population norms were shown in all domains of the SF-36. There were no significant differences in the SF-36 scores among the patients according to clinicopathological subset or disease course. CONCLUSIONS: Although the mortality of our cohort was favourable, myositis continues to have a great impact on life in the medium and long term. The present work indicates that myositis patients have a significantly poorer quality of life than the normal population, but there was no difference among the patients according to clinicopathological subsets. | |
| dc.relation.ispartof | urn:issn:1462-0324 | |
| dc.title | Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis | |
| dc.type | Journal Article | |
| dc.date.updated | 2017-04-05T08:51:48Z | |
| dc.language.rfc3066 | en | |
| dc.identifier.mtmt | 1633279 | |
| dc.identifier.wos | 000226187300015 | |
| dc.identifier.pubmed | 15381789 | |
| dc.contributor.department | SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika | |
| dc.contributor.institution | Semmelweis Egyetem |